Mutational survivorship bias: The case of PNKP

Por um escritor misterioso
Last updated 15 março 2025
Mutational survivorship bias: The case of PNKP
The molecular function of a protein relies on its structure. Understanding how variants alter structure and function in multidomain proteins is key to elucidate the generation of a pathological phenotype. However, one may fall into the logical bias of assessing protein damage only based on the variants that are visible (survivorship bias), which can lead to partial conclusions. This is the case of PNKP, an important nuclear and mitochondrial DNA repair enzyme with both kinase and phosphatase function. Most variants in PNKP are confined to the kinase domain, leading to a pathological spectrum of three apparently distinct clinical entities. Since proteins and domains may have a different tolerability to variation, we evaluated whether variants in PNKP are under survivorship bias. Here, we provide the evidence that supports a higher tolerance in the kinase domain even when all variants reported are deleterious. Instead, the phosphatase domain is less tolerant due to its lower variant rates, a higher degree of sequence conservation, lower dN/dS ratios, and the presence of more disease-propensity hotspots. Together, our results support previous experimental evidence that demonstrated that the phosphatase domain is functionally more necessary and relevant for DNA repair, especially in the context of the development of the central nervous system. Finally, we propose the term "Wald’s domain" for future studies analyzing the possible survivorship bias in multidomain proteins.
Mutational survivorship bias: The case of PNKP
Mutations of the DNA repair gene PNKP in a patient with microcephaly, seizures, and developmental delay (MCSZ) presenting with a high-grade brain tumor
Mutational survivorship bias: The case of PNKP
Association of PTPRT mutations with immune checkpoint inhibitors response and outcome in melanoma and non‐small cell lung cancer - Zhang - 2022 - Cancer Medicine - Wiley Online Library
Mutational survivorship bias: The case of PNKP
A synthetically lethal nanomedicine delivering novel inhibitors of polynucleotide kinase 3′-phosphatase (PNKP) for targeted therapy of PTEN-deficient colorectal cancer - ScienceDirect
Mutational survivorship bias: The case of PNKP
Analysis of Copy Number Variation of DNA Repair/Damage Response Genes in Tumor Tissues
Mutational survivorship bias: The case of PNKP
Novel PNKP mutations causing defective DNA strand break repair and PARP1 hyperactivity in MCSZ
Mutational survivorship bias: The case of PNKP
Species variations in XRCC1 recruitment strategies for FHA domain-containing proteins - ScienceDirect
Mutational survivorship bias: The case of PNKP
Browse Preprints - Authorea
Mutational survivorship bias: The case of PNKP
Prenatal phenotype of PNKP-related primary microcephaly associated with variants affecting both the FHA and phosphatase domain
Mutational survivorship bias: The case of PNKP
Mutational survivorship bias: The case of PNKP
Mutational survivorship bias: The case of PNKP
Oropharyngeal cancer outcomes correlate with p16 status, multinucleation and immune infiltration - Modern Pathology

© 2014-2025 videoanalitik.net. All rights reserved.